Related Experiment Videos
Hypercholesterolemia in diabetics with clinically unrecognised primary thyroid failure
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|September 1, 1981
Summary
Subclinical hypothyroidism in diabetics elevates cholesterol levels, increasing heart disease risk. Thyroxine therapy can reverse this, improving outcomes for diabetic patients with thyroid dysfunction.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Cardiovascular Health
Background:
- Diabetes mellitus is associated with an increased risk of cardiovascular disease.
- Thyroid dysfunction, particularly hypothyroidism, can impact lipid metabolism.
- Subclinical hypothyroidism, defined by elevated thyroid-stimulating hormone (TSH) with normal thyroxine (T4) levels, is common.
Purpose of the Study:
- To investigate the relationship between subclinical thyroid failure and plasma lipid profiles in diabetic patients.
- To determine if unrecognized thyroid dysfunction contributes to hypercholesterolemia in diabetes.
- To assess the effect of thyroxine replacement therapy on lipid levels in these patients.
Main Methods:
- Comparison of plasma cholesterol and triglyceride concentrations between diabetic patients with and without subclinical hypothyroidism.
- Assessment of TSH and T4 levels to diagnose thyroid status.
- Evaluation of lipid changes following thyroxine replacement therapy in a subset of patients.
Main Results:
- Diabetic patients with subclinical hypothyroidism exhibited significantly higher mean plasma cholesterol concentrations compared to euthyroid diabetic controls.
- No significant difference in triglyceride concentrations was observed between the groups.
- Thyroxine replacement therapy in patients with subnormal T4 levels led to a significant reduction in plasma cholesterol.
Conclusions:
- Clinically unrecognized thyroid failure in diabetics is associated with reversible hypercholesterolemia.
- This hypercholesterolemia may contribute to the elevated risk of ischemic heart disease in diabetic populations.
- Screening for thyroid dysfunction in diabetic patients is warranted to manage lipid abnormalities and potentially reduce cardiovascular risk.